The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: A beneficial "side effect" of an OTC antidepressant drug?

Free Radical Research

Volumn 41, Issue 2, 2007, Pages 234-241

  Laggner, Hilde ^a   Schreier, Sabine ^a   Hermann, Marcela ^b   Exner, Markus ^a   Mühl, Adolf ^a   Gmeiner, Bernhard M K ^a   Kapiotis, Stylianos ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Central Laboratory   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; COPPER; HYDROGEN PEROXIDE; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MYELOPEROXIDASE; PSEUDOHYPERICIN; TYROSINE; ANTIOXIDANT; BICYCLO COMPOUND; DRUG DERIVATIVE; NON PRESCRIPTION DRUG; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXIDASE; PERYLENE; PHLOROGLUCINOL; TERPENE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THROMBOPLASTIN;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIPID OXIDATION; NONHUMAN; ULTRACENTRIFUGATION; ATHEROSCLEROSIS; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; DEPRESSION; DRUG EFFECT; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERICUM; MASS SPECTROMETRY; METABOLISM; OXIDATION REDUCTION REACTION; PHYTOTHERAPY; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION; UMBILICAL VEIN;

HYPERICUM PERFORATUM;

ANTIDEPRESSIVE AGENTS; ANTIOXIDANTS; ATHEROSCLEROSIS; BICYCLO COMPOUNDS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; DEPRESSION; DRUG EVALUATION, PRECLINICAL; DRUGS, NON-PRESCRIPTION; ENDOTHELIAL CELLS; HUMANS; HYPERICUM; LIPOPROTEINS, LDL; MALONDIALDEHYDE; MASS SPECTROMETRY; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PEROXIDASE; PERYLENE; PHLOROGLUCINOL; PHYTOTHERAPY; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; TERPENES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THROMBOPLASTIN; TYROSINE; UMBILICAL VEINS;

EID: 34250792112     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760600978831     Document Type: Article

References (27)

1. Wong, AH, Smith, M. and Boon, HS (1998) Herbal remedies in psychiatric practice. Arch Gen Psychiatry, 55, pp. 1033-1044.
2. Szegedi, A., Kohnen, R., Dienel, A. and Kieser, M. (2005) Acute treatment of moderate to severe depression with Hypericum extract WS 5570 (St John's wort): Randomised controlled double blind non-inferiority trial versus paroxetine. BMJ, 330, p. 503.
3. Barnes, PM, Powell-Griner, E., McFann, K. and Nahin, RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data, pp. 1-19.
4. Tsuboi, H., Tatsumi, A., Yamamoto, K., Kobayashi, F., Shimoi, K. and Kinae, N. (2006) Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J Affect Disord, 91, pp. 63-70.
5. Sarandol, A., Sarandol, E., Eker, SS, Karaagac, EU, Hizli, BZ, Dirican, M. and Kirli, S. (2006) Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry
6. Bilici, M., Efe, H., Koroglu, MA, Uydu, HA, Bekaroglu, M. and Deger, O. (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments. J Affect Disord, 64, pp. 43-51.
7. Maes, M., De Vos, N., Pioli, R., Demedts, P., Wauters, A., Neels, H. and Christophe, A. (2000) Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord, 58, pp. 241-246.
8. Esterbauer, H., Gebicki, J., Puhl, H. and Jurgens, G. (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med, 13, pp. 341-390.
9. Musselman, DL, Evans, DL and Nemeroff, CB (1998) The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch Gen Psychiatry, 55, pp. 580-592.
10. Jones, DJ, Bromberger, JT, Sutton-Tyrrell, K. and Matthews, KA (2003) Lifetime history of depression and carotid atherosclerosis in middle-aged women. Arch Gen Psychiatry, 60, pp. 153-160.
11. Tiemeier, H., van Dijck, W., Hofman, A., Witteman, JC, Stijnen, T. and Breteler, MM (2004) Relationship between atherosclerosis and late-life depression: The rotterdam study. Arch Gen Psychiatry, 61, pp. 369-376.
12. Steinberg, D., Parthasarathy, S., Carew, TE, Khoo, JC and Witztum, JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med, 320, pp. 915-924.
13. Berliner, JA, Navab, M., Fogelman, AM, Frank, JS, Demer, LL, Edwards, PA, Watson, AD and Lusis, AJ (1995) Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation, 91, pp. 2488-2496.
14. Kaliora, AC, Dedoussis, GV and Schmidt, H. (2006) Dietary antioxidants in preventing atherogenesis. Atherosclerosis, 187, pp. 1-17.
15. Hermann, M. and Gmeiner, B. (1992) Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates. Arterioscler Thromb, 12, pp. 1503-1506.
16. Lowry, OH, Rosebrough, NJ, Farr, AL and Randall, RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem, 193, pp. 265-275.
17. Kapiotis, S., Besemer, J., Bevec, D., Valent, P., Bettelheim, P., Lechner, K. and Speiser, W. (1991) Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood, 78, pp. 410-415.
18. Laggner, H., Hermann, M., Sturm, B., Gmeiner, BM and Kapiotis, S. (2005) Sulfite facilitates LDL lipid oxidation by transition metal ions: A pro-oxidant in wine?. FEBS Lett, 579, pp. 6486-6492.
19. Tolonen, A., Uusitalo, J., Hohtola, A. and Jalonen, J. (2002) Determination of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom, 16, pp. 396-402.
20. Kapiotis, S., Hermann, M., Exner, M., Laggner, H. and Gmeiner, BM (2005) Copper- and magnesium protoporphyrin complexes inhibit oxidative modification of LDL induced by hemin, transition metal ions and tyrosyl radicals. Free Radic Res, 39, pp. 1193-1202.
21. Halliwell, B. and Gutteridge, JMC (1999) Free radicals in biology and medicine, Oxford University Press, Oxford
22. Falk, H. (1999) From the photosensitizer hypericin to the photoreceptor stentorin- the chemistry of phenanthroperylene quinones. Angew Chem Int Ed Engl, 38, pp. 3116-3136.
23. Williams, RJ, Spencer, JP and Rice-Evans, C. (2004) Flavonoids: Antioxidants or signaling molecules?. Free Radic Biol Med, 36, pp. 838-849.
24. Taylor, CB, Youngblood, ME, Catellier, D., Veith, RC, Carney, RM, Burg, MM, Kaufmann, PG, Shuster, J., Mellman, T., Blumenthal, JA, Krishnan, R. and Jaffe, AS (2005) Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry, 62, pp. 792-798.
25. Leitinger, N. (2005) Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res, 49, pp. 1063-1071.
26. Schulz, HU, Schurer, M., Bassler, D. and Weiser, D. (2005) Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a Hypericum extract containing tablet in healthy male volunteers. Arzneimittelforschung, 55, pp. 561-568.
27. Delaey, EM, Obermueller, R., Zupko, I., De Vos, D., Falk, H. and de Witte, PA (2001) In vitro study of the photocytotoxicity of some hypericin analogs on different cell lines. Photochem Photobiol, 74, pp. 164-171.